Regeneron Pharmaceuticals
REGN
#226
Rank
HK$636.62 B
Marketcap
HK$5,793
Share price
0.15%
Change (1 day)
-6.97%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): HK$292.58

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$290.72. In 2022 the company made an earnings per share (EPS) of HK$315.31 a decrease over its 2021 EPS that were of HK$594.90.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$292.58-7.21%
2022HK$315.31-47%
2021HK$594.90133.36%
2020HK$254.9269.13%
2019HK$150.73-14.44%
2018HK$176.17100.71%
2017HK$87.7831.78%
2016HK$66.6138.96%
2015HK$47.9372.55%
2014HK$27.78-17.55%
2013HK$33.69-44.98%
2012HK$61.24-422.54%
2011-HK$18.9992.13%
2010-HK$9.8849.41%
2009-HK$6.61-15.84%
2008-HK$7.86-36.88%
2007-HK$12.45-9.6%
2006-HK$13.774.12%
2005-HK$13.23-323.68%
2004HK$5.91-135.51%
2003-HK$16.65-24.38%
2002-HK$22.0256.35%
2001-HK$14.08187.3%
2000-HK$4.90-16%
1999-HK$5.84177.78%
1998-HK$2.10-35.71%
1997-HK$3.27-68.42%
1996-HK$10.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$110.11-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$31.98-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$143.65-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.60-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$29.10-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$24.75-91.49%๐Ÿ‡ซ๐Ÿ‡ท France